{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:34:56Z","timestamp":1789126496937,"version":"build-2803163510"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ccm.2022.10.001","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T18:42:35Z","timestamp":1675968155000},"page":"15-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Lung Transplant Candidate, Indications, Timing, and Selection Criteria"],"prefix":"10.1016","volume":"44","author":[{"given":"Hannah","family":"Mannem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha G.","family":"Kapnadak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ccm.2022.10.001_bib1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.ccm.2022.10.001_bib2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics","volume":"40","author":"Chambers","year":"2021","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2022.10.001_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ajt.16991","article-title":"OPTN\/SRTR 2020 annual data report: lung","volume":"22","author":"Valapour","year":"2022","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.healun.2016.01.010","article-title":"Effect of the lung allocation score on lung transplantation in the United States","volume":"35","author":"Egan","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.healun.2021.11.002","article-title":"Geographic disparities in lung transplantation in the United States before and after the November 2017 allocation change","volume":"41","author":"Benvenuto","year":"2022","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.healun.2018.09.007","article-title":"Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes","volume":"38","author":"Mooney","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0037-1620265","article-title":"How should lungs be allocated for transplant?","volume":"39","author":"Egan","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jcf.2015.11.005","article-title":"Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States","volume":"15","author":"Ramos","year":"2016","journal-title":"J\u00a0Cyst Fibros"},{"issue":"7","key":"10.1016\/j.ccm.2022.10.001_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1513\/AnnalsATS.201810-713OC","article-title":"Association between allosensitization and waiting list outcomes among adult lung transplant candidates in the United States","volume":"16","author":"Tague","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.ccm.2022.10.001_bib10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.10.001_bib11","author":"Network OPaT"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"12","key":"10.1016\/j.ccm.2022.10.001_bib13","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.healun.2018.07.015","article-title":"Pre-transplant weight loss and clinical outcomes after lung transplantation","volume":"37","author":"Clausen","year":"2018","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.ccm.2022.10.001_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.healun.2013.04.002","article-title":"Pulmonary rehabilitation in lung transplant candidates","volume":"32","author":"Li","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5500\/wjt.v6.i3.517","article-title":"Physical rehabilitation for lung transplant candidates and recipients: an evidence-informed clinical approach","volume":"6","author":"Wickerson","year":"2016","journal-title":"Worldj Transpl"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.09-1002","article-title":"Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study","volume":"137","author":"Fern\u00e1ndez P\u00e9rez","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1183\/09031936.02.00182002","article-title":"Clinical significance of histological classification of idiopathic interstitial pneumonia","volume":"19","author":"Flaherty","year":"2002","journal-title":"Eur Respir J"},{"issue":"22","key":"10.1016\/j.ccm.2022.10.001_bib18","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A\u00a0phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201602-0402OC","article-title":"Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria","volume":"195","author":"Raghu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"10.1016\/j.ccm.2022.10.001_bib20","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-2600(16)30326-5","article-title":"Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis","volume":"5","author":"Nathan","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"19","key":"10.1016\/j.ccm.2022.10.001_bib22","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"161","key":"10.1016\/j.ccm.2022.10.001_bib23","doi-asserted-by":"crossref","first-page":"210017","DOI":"10.1183\/16000617.0017-2021","article-title":"Lung transplantation for interstitial lung disease","volume":"30","author":"Kapnadak","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.201011-1790OC","article-title":"Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis","volume":"184","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2022.10.001_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A\u00a0multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ccm.2022.10.001_bib26","first-page":"3828","article-title":"Predictors of mortality in patients with interstitial lung disease-associated pulmonary hypertension","volume":"9","author":"Alhamad","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib27","doi-asserted-by":"crossref","first-page":"e180029","DOI":"10.1148\/ryct.2019180029","article-title":"Predicting outcome in idiopathic pulmonary fibrosis: addition of fibrotic score at thin-section ct of the chest to gender, age, and physiology score improves the prediction model","volume":"1","author":"Chahal","year":"2019","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02718-2020","article-title":"Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)","volume":"57","author":"Nasser","year":"2021","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ccm.2022.10.001_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"150","key":"10.1016\/j.ccm.2022.10.001_bib30","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"18","key":"10.1016\/j.ccm.2022.10.001_bib31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"26","key":"10.1016\/j.ccm.2022.10.001_bib33","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/thoraxjnl-2019-213620","article-title":"Risk factors for disease progression in idiopathic pulmonary fibrosis","volume":"75","author":"Raghu","year":"2020","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12931-019-1043-9","article-title":"Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry","volume":"20","author":"Snyder","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2022.10.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.05.020","article-title":"Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: a cohort study","volume":"154","author":"Ratwani","year":"2019","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/resp.12945","article-title":"A\u00a0simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease","volume":"22","author":"Khadawardi","year":"2017","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib39","first-page":"242","article-title":"Progression of right ventricular dysfunction and predictors of mortality in patients with idiopathic interstitial pneumonias","volume":"75","author":"Amano","year":"2020","journal-title":"J\u00a0Cardiol"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.athoracsur.2015.06.024","article-title":"Influence of pulmonary hypertension on patients with idiopathic pulmonary fibrosis awaiting lung transplantation","volume":"101","author":"Hayes","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.ccm.2022.10.001_bib41","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.201007-1179OC","article-title":"Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference","volume":"183","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2022.10.001_bib42","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2022.10.001_bib43","doi-asserted-by":"crossref","first-page":"l5358","DOI":"10.1136\/bmj.l5358","article-title":"Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal","volume":"367","author":"Bellou","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.chest.2017.10.008","article-title":"Survival of lung transplant candidates with COPD: BODE score reconsidered","volume":"153","author":"Reed","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2022.10.001_bib45","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.2147\/COPD.S182483","article-title":"Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation","volume":"13","author":"Pirard","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"10.1016\/j.ccm.2022.10.001_bib46","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1164\/rccm.200708-1283OC","article-title":"Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease","volume":"177","author":"Thabut","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib47","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.107.5.1193","article-title":"Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure","volume":"107","author":"Oswald-Mammosser","year":"1995","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib48","doi-asserted-by":"crossref","first-page":"1901812","DOI":"10.1183\/13993003.01812-2019","article-title":"Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene","volume":"55","author":"LaFon","year":"2020","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.ccm.2022.10.001_bib49","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/rccm.200510-1677OC","article-title":"Predictors of mortality in patients with emphysema and severe airflow obstruction","volume":"173","author":"Martinez","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.200709-1383OC","article-title":"Longitudinal change in the BODE index predicts mortality in severe emphysema","volume":"178","author":"Martinez","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"10.1016\/j.ccm.2022.10.001_bib51","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/jama.1995.03530230038027","article-title":"Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease","volume":"274","author":"Seneff","year":"1995","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccm.2022.10.001_bib52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0885066620944865","article-title":"Outcomes and resource utilization among patients admitted to the intensive care unit following acute exacerbation of chronic obstructive pulmonary disease","volume":"36","author":"Warwick","year":"2021","journal-title":"J\u00a0Intensive Care Med"},{"issue":"10212","key":"10.1016\/j.ccm.2022.10.001_bib53","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ccm.2022.10.001_bib54","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa2100665","article-title":"Triple therapy for cystic fibrosis phe508del-gating and -residual function genotypes","volume":"385","author":"Barry","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"10.1016\/j.ccm.2022.10.001_bib56","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2022.10.001_bib57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-2600(20)30510-5","article-title":"Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study","volume":"9","author":"Flume","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcf.2018.07.011","article-title":"Lumacaftor\/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV(1)","volume":"18","author":"McColley","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic fibrosis foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2022.10.001_bib60","first-page":"S69","article-title":"Enhancing care for individuals with advanced cystic fibrosis lung disease","volume":"56","author":"Kapnadak","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"18","key":"10.1016\/j.ccm.2022.10.001_bib61","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib62","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1378\/chest.113.5.1230","article-title":"Risk of death in cystic fibrosis patients with severely compromised lung function","volume":"113","author":"Milla","year":"1998","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2022.10.001_bib63","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.chest.2017.01.019","article-title":"Heterogeneity in survival in adult patients with cystic fibrosis with FEV(1) < 30% of predicted in the United States","volume":"151","author":"Ramos","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib64","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.athoracsur.2015.04.022","article-title":"Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation","volume":"100","author":"Hayes","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib65","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.201902-0252OC","article-title":"Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease","volume":"200","author":"Lehr","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2022.10.001_bib66","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200410-1369OC","article-title":"Risk factors for death of patients with cystic fibrosis awaiting lung transplantation","volume":"173","author":"Belkin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib67","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thx.2011.161117","article-title":"Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis","volume":"66","author":"de Boer","year":"2011","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib68","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1164\/rccm.201407-1382OC","article-title":"Pulmonary hypertension in cystic fibrosis with advanced lung disease","volume":"190","author":"Hayes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib69","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.athoracsur.2015.09.086","article-title":"Pulmonary artery pressure and benefit of lung transplantation in adult cystic fibrosis patients","volume":"101","author":"Hayes","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.ccm.2022.10.001_bib70","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.rmed.2013.10.001","article-title":"Prognostic value of six minute walk test in cystic fibrosis adults","volume":"107","author":"Martin","year":"2013","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib71","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s00270-017-1626-0","article-title":"Outcomes following bronchial artery embolisation for haemoptysis in cystic fibrosis","volume":"40","author":"Flight","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"22","key":"10.1016\/j.ccm.2022.10.001_bib72","first-page":"01049","article-title":"Development and internal validation of a prognostic model of 2-year death or lung transplant for cystic fibrosis","volume":"S0012-3692","author":"Ramos","year":"2022","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib73","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib75","doi-asserted-by":"crossref","first-page":"1700740","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the reveal risk score calculator 2.0 and comparison with ESC\/ERS-Based Risk ASSESSMENT STrategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2022.10.001_bib77","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.healun.2017.10.028","article-title":"Impact of declining renal function on outcomes in pulmonary arterial hypertension: a REVEAL registry analysis","volume":"37","author":"Chakinala","year":"2018","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"24","key":"10.1016\/j.ccm.2022.10.001_bib78","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib79","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.healun.2018.11.015","article-title":"The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension","volume":"38","author":"Badagliacca","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib80","doi-asserted-by":"crossref","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2022.10.001_bib81","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.rmed.2010.03.014","article-title":"Pulmonary veno-occlusive disease: recent progress and current challenges","volume":"104","author":"Montani","year":"2010","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib82","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/art.40862","article-title":"Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis","volume":"71","author":"Young","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib83","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1164\/rccm.200810-1603OC","article-title":"Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension","volume":"180","author":"Chen","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccm.2022.10.001_bib84","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.healun.2013.08.016","article-title":"Survival in pulmonary arterial hypertension patients awaiting lung transplantation","volume":"32","author":"Gomberg-Maitland","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib85","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.athoracsur.2017.02.034","article-title":"Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension","volume":"104","author":"Savale","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib86","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0041-1729541","article-title":"The lung allocation score and its relevance","volume":"42","author":"Lyu","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40256-018-00319-z","article-title":"Improving survival in patients with pulmonary arterial hypertension: focus on intravenous epoprostenol","volume":"19","author":"Demerouti","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ccm.2022.10.001_bib88","doi-asserted-by":"crossref","first-page":"106685","DOI":"10.1016\/j.rmed.2021.106685","article-title":"Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit","volume":"190","author":"Garcia","year":"2021","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib89","doi-asserted-by":"crossref","first-page":"2100466","DOI":"10.1183\/13993003.00466-2021","article-title":"Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure","volume":"58","author":"Savale","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib90","doi-asserted-by":"crossref","first-page":"1801906","DOI":"10.1183\/13993003.01906-2018","article-title":"Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension","volume":"53","author":"Hoeper","year":"2019","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2022.10.001_bib91","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"17","key":"10.1016\/j.ccm.2022.10.001_bib92","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ccm.2022.10.001_bib93","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","article-title":"Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis","volume":"190","author":"Yao","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib94","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis","volume":"155","author":"Gupta","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib97","first-page":"92","article-title":"Lung transplantation for pulmonary sarcoidosis","volume":"36","author":"Meyer","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib98","doi-asserted-by":"crossref","first-page":"2003358","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: outcome and prognostic factors","volume":"58","author":"Le Pavec","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib99","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.rmed.2009.02.001","article-title":"Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis","volume":"103","author":"Akagi","year":"2009","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/resp.13387","article-title":"Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis","volume":"24","author":"Yoon","year":"2019","journal-title":"Respirology"},{"issue":"23","key":"10.1016\/j.ccm.2022.10.001_bib101","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib102","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/TP.0000000000002004","article-title":"Lung transplantation as a therapeutic option in acute respiratory distress syndrome","volume":"102","author":"Chang","year":"2018","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ccm.2022.10.001_bib103","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.athoracsur.2015.05.088","article-title":"Long-term venovenous extracorporeal membrane oxygenation support for acute respiratory distress syndrome","volume":"100","author":"Kon","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"21","key":"10.1016\/j.ccm.2022.10.001_bib104","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0003-4975(97)01191-0","article-title":"Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry","volume":"65","author":"Novick","year":"1998","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1164\/rccm.200707-1132OC","article-title":"Outcomes after lung retransplantation in the modern era","volume":"177","author":"Kawut","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib107","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/ajt.13281","article-title":"Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study","volume":"15","author":"Verleden","year":"2015","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib108","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.athoracsur.2016.09.107","article-title":"Two decades of lung retransplantation: a single-center experience","volume":"103","author":"Hall","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib109","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.athoracsur.2019.04.028","article-title":"Outcomes and long-term survival after pulmonary retransplantation: a single-center experience","volume":"108","author":"Wallinder","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.ccm.2022.10.001_bib110","doi-asserted-by":"crossref","first-page":"900","DOI":"10.21037\/atm-20-4934","article-title":"Esophageal disease in lung transplant patients","volume":"9","author":"Young","year":"2021","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib111","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1067\/mtc.2003.166","article-title":"Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation","volume":"125","author":"Davis","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib112","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.athoracsur.2011.04.035","article-title":"Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux","volume":"92","author":"Hartwig","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.ccm.2022.10.001_bib113","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archsurg.2011.216","article-title":"Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation","volume":"146","author":"Hoppo","year":"2011","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thorsurg.2012.08.001","article-title":"Psychosocial issues facing lung transplant candidates, recipients and family caregivers","volume":"22","author":"Rosenberger","year":"2012","journal-title":"Thorac Surg Clin"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib116","doi-asserted-by":"crossref","first-page":"e12874","DOI":"10.1111\/ctr.12874","article-title":"Depressive symptoms and early mortality following lung transplantation: a pilot study","volume":"31","author":"Smith","year":"2017","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/ajt.13447","article-title":"Psychosocial predictors of mortality following lung transplantation","volume":"16","author":"Smith","year":"2016","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib118","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/tri.13094","article-title":"Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study","volume":"31","author":"Smith","year":"2018","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib119","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1191\/1479972306cd082ra","article-title":"To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation","volume":"3","author":"Dobbels","year":"2006","journal-title":"Chron Respir Dis"},{"issue":"7","key":"10.1016\/j.ccm.2022.10.001_bib120","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.healun.2018.03.003","article-title":"Lung transplantation for scleroderma lung disease: an international, multicenter, observational cohort study","volume":"37","author":"Prad\u00e8re","year":"2018","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib121","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.athoracsur.2017.09.038","article-title":"Long-term survival in bilateral lung transplantation for scleroderma-related lung disease","volume":"105","author":"Chan","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib122","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcf.2021.12.001","article-title":"Low body mass index as a barrier to lung transplant in cystic fibrosis","volume":"21","author":"Jennerich","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib123","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.chest.2019.11.043","article-title":"Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united Network for organ sharing registry study","volume":"157","author":"Ramos","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib124","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.healun.2014.09.028","article-title":"Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry","volume":"34","author":"Hayanga","year":"2015","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib125","doi-asserted-by":"crossref","first-page":"e13084","DOI":"10.1111\/tid.13084","article-title":"Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience","volume":"21","author":"Perez","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib126","doi-asserted-by":"crossref","first-page":"e13046","DOI":"10.1111\/tid.13046","article-title":"Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series","volume":"21","author":"Raats","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib127","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/ajt.16318","article-title":"Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib128","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ajt.16324","article-title":"Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transpl"},{"issue":"8","key":"10.1016\/j.ccm.2022.10.001_bib129","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200605-587ST","article-title":"An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses","volume":"177","author":"Lanken","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2022.10.001_bib130","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1513\/AnnalsATS.201805-347HP","article-title":"Palliative care in advanced lung diseases: a void that needs filling","volume":"15","author":"Ruggiero","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib131","doi-asserted-by":"crossref","first-page":"1702645","DOI":"10.1183\/13993003.02645-2017","article-title":"Palliative care for people with COPD: effective but underused","volume":"51","author":"Halpin","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib132","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jtcvs.2014.08.072","article-title":"Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease","volume":"149","author":"Hayanga","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ccm.2022.10.001_bib133","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.jtcvs.2019.02.048","article-title":"Twenty-year experience with extracorporeal life support as bridge to lung transplantation","volume":"157","author":"Benazzo","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib134","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jtcvs.2017.09.161","article-title":"Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center","volume":"155","author":"Hoetzenecker","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.ccm.2022.10.001_bib135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201109-1599OC","article-title":"Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation","volume":"185","author":"Fuehner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.10.001_bib136","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.healun.2013.06.009","article-title":"Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France","volume":"32","author":"Lafarge","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.ccm.2022.10.001_bib137","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.athoracsur.2016.11.056","article-title":"Awake extracorporeal membrane oxygenation as bridge to lung transplantation: a 9-year experience","volume":"104","author":"Biscotti","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib138","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/icvts\/ivv379","article-title":"Extracorporeal membrane oxygenation as a bridge to lung transplantation: what lessons might we learn from volume and expertise?","volume":"22","author":"Hayanga","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccc.2018.08.006","article-title":"Bridging to lung transplantation","volume":"35","author":"Mattar","year":"2019","journal-title":"Crit Care Clin"},{"issue":"4","key":"10.1016\/j.ccm.2022.10.001_bib140","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1016\/j.healun.2020.01.709","article-title":"Approaches to the management of sensitized lung transplant candidates: findings from an international survey","volume":"39","author":"Aversa","year":"2020","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.ccm.2022.10.001_bib141","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/cc13746","article-title":"Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study","volume":"18","author":"Abrams","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ccm.2022.10.001_bib142","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.xjtc.2021.07.004","article-title":"Commentary: walking wounded: role of ambulatory femoral venovenous extracorporeal membrane oxygenation","volume":"9","author":"Georges","year":"2021","journal-title":"JTCVS Tech"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib143","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.athoracsur.2018.10.048","article-title":"Ambulation with femoral arterial cannulation can Be safely performed on venoarterial extracorporeal membrane oxygenation","volume":"107","author":"Pasrija","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"20","key":"10.1016\/j.ccm.2022.10.001_bib144","first-page":"30997","article-title":"Urgently listed lung transplant patients have outcomes similar to those of electively listed patients","volume":"S0022-5223","author":"Tang","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.ccm.2022.10.001_bib145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.healun.2022.01.017","article-title":"Long-term outcome and bridging success of patients evaluated and bridged to lung transplantation on the ICU","volume":"41","author":"Gan","year":"2022","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"574","key":"10.1016\/j.ccm.2022.10.001_bib146","doi-asserted-by":"crossref","first-page":"eabe4282","DOI":"10.1126\/scitranslmed.abe4282","article-title":"Lung transplantation for patients with severe COVID-19","volume":"12","author":"Bharat","year":"2020","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.10.001_bib147","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.healun.2021.11.013","article-title":"The effect of the cystic fibrosis care center on outcomes after lung transplantation for cystic fibrosis","volume":"41","author":"Bush","year":"2022","journal-title":"J\u00a0Heart Lung Transpl"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523122001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523122001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:16:41Z","timestamp":1759454201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523122001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0272523122001034"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2022.10.001","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Lung Transplant Candidate, Indications, Timing, and Selection Criteria","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}